Suchergebnisse - "Hernández-Rodríguez, José"

PubPharm (6)

1

Efficacy and safety of TNF-α antagonists and tocilizumab in Takayasu arteritis : multicentre retrospective study of 209 patients

enthalten in: Rheumatology (Oxford, England) | 2022

von Mekinian, A. | Biard, L. | Dagna, L. | +52

2

Response to mepolizumab according to disease manifestations in patients with eosinophilic granulomatosis with polyangiitis

enthalten in: European journal of internal medicine | 2022

von Ríos-Garcés, R. | Prieto-González, S. | Hernández-Rodríguez, J. | +5

3

Drug survival of anakinra and canakinumab in monogenic autoinflammatory diseases : observational study from the International AIDA Registry

enthalten in: Rheumatology (Oxford, England) | 2021

von Sota, J. | Rigante, D. | Cimaz, R. | +24

4

New Potential Weapons for Refractory Scleritis in the Era of Targeted Therapy

enthalten in: Mediators of inflammation | 2020

von Fabiani, C. | Sota, J. | Sainz-de-la-Maza, M. | +11

5

Biological treatments in giant cell arteritis & Takayasu arteritis

enthalten in: European journal of internal medicine | 2018

von Samson, M. | Espígol-Frigolé, G. | Terrades-García, N. | +7

6

Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis

enthalten in: The New England journal of medicine | 2017

von Wechsler, M. | Akuthota, P. | Jayne, D. | +56

CommentIn: Nat Rev Rheumatol. 2017 Sep;13(9):518-519. - PMID 28769112

1
[1]